CARDIOVASCULAR EVENT RISK PREDICTION

Biomarkers, methods, devices, reagents, systems, and kits used to assess an individual having heart failure with preserved ejection fraction (HFpEF) or having heart failure with reduced ejection fraction (HFrEF) for the prediction of risk of developing a Cardiovascular (CV) Event over a 90 day, 180...

Full description

Saved in:
Bibliographic Details
Main Authors JIA, Yi, OSTROFF, Rachel Marie, HAGAR, Yolanda, SAMPSON, Laura Mae, HINTERBERG, Michael Albert
Format Patent
LanguageEnglish
French
Published 28.04.2022
Subjects
INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES
MEASURING
PHYSICS
TESTING
Online AccessGet full text

Cover

More Information
Summary:Biomarkers, methods, devices, reagents, systems, and kits used to assess an individual having heart failure with preserved ejection fraction (HFpEF) or having heart failure with reduced ejection fraction (HFrEF) for the prediction of risk of developing a Cardiovascular (CV) Event over a 90 day, 180 day, or 1 year period are provided. L'invention concerne des biomarqueurs, des méthodes, des dispositifs, des réactifs, des systèmes et des kits utilisés pour évaluer un individu ayant une insuffisance cardiaque à fraction d'éjection préservée (ICFEP) ou ayant une insuffisance cardiaque à fraction d'éjection réduite (ICFER) afin de prédire le risque de développer un événement cardiovasculaire (CV) sur une période de 90 jours, de 180 jours ou d'un an.
Bibliography:Application Number: WO2021US55537